RISK ASSESSMENT AND
MANAGEMENT
|
|
|
Fanny K. Ennever |
|
Fall Term, 2003 |
Risk Assessment
|
|
|
Risk assessment the process of
correlating the amount of exposure with the amount of harm. |
|
|
|
The question: |
|
How much of a chemical is OK? |
Steps in Risk Assessment
|
|
|
|
Hazard identification |
|
Exposure assessment (DOSE) |
|
Quantitative toxicological assessment (DOSE-RESPONSE) |
|
Risk characterization |
|
|
Risk Management
|
|
|
|
Decisions on whether to act and how |
|
Uses the numbers from risk assessment |
|
Considers cost of alternatives |
|
Is influenced by risk perception |
1. Hazard Identification
|
|
|
Toxicological concepts: |
|
Any substance is toxic if dose is high
enough, but only some chemicals can cause cancer |
|
Non-cancer toxicity: Protecting against
the most sensitive effect protects against all effects: “threshold” |
|
Cancer: Any dose of a carcinogen
carries some risk, but the smaller the dose, the smaller the risk |
Key question for hazard
identification:
Is it a carcinogen or not?
|
|
|
Current methods: |
|
Epidemiology |
|
Animal testing |
|
In vitro (bacterial and mammalian cell)
testing |
|
Structure-activity relationships |
Scope of the identification
problem
|
|
|
|
Synthetic chemicals cause only |
|
1-5% of all human cancers |
|
>1
million chemical substances are known |
|
~3 thousand produced in high volumes |
|
Full
information available for 7% |
|
No
information available for 43% |
|
Tests (mutagenicity but not
carcinogenicity)
cost $200,000 per chemical |
Questions in Hazard
Identification
|
|
|
|
Is human cancer predicted well enough
by |
|
animal cancer tests? |
|
mutagenicity? |
|
Are we controlling the right chemicals? |
2. Exposure Assessment
Who’s Exposure?
|
|
|
Numerical estimate of exposure |
|
Must know frequency and duration of contact |
|
Depends on physiology and activities |
|
|
|
Uncertainty |
|
Report both central tendency and upper
bound values |
|
|
Example – methylene
chloride (MC) in soil
|
|
|
Adult central tendency soil ingestion: |
3. Quantitative
Toxicological
Assessment
|
|
|
Non-Cancer Toxicity (has a threshold) |
|
|
|
Determine which species, durations, and
endpoints have been studied |
|
ß |
|
Identify the most sensitive
effect |
|
No Observed Adverse Effect Level: NOAEL (or Lowest Observed Adverse Effect Level:
LOAEL) |
|
ß |
|
|
Non-Cancer Toxicity
(continued)
|
|
|
NOAEL (or LOAEL) |
|
ß |
|
Use uncertainty factors to account for within-human variability
(¸10), animal-to-human |
|
variability (¸10), threshold (¸10), durations (¸10), and completeness of data (¸10) |
|
ß |
|
“Safe” dose = RfD |
Derivation of Reference
Dose (RfD)
Example – methylene
chloride RfD
|
|
|
NOAEL: 5.85 (male mice) and 6.47
(female mice) mg/kg/day, liver toxicity |
|
Uncertainty factors: 10 for
within-human variability and 10 for animal-to-human variability |
|
RfD = 6 × 10-2 mg/kg/day |
Only if the chemical is a
“carcinogen”
|
|
|
Cancer toxicity (no threshold) |
|
|
|
Identify the most sensitive tumor |
|
ß |
|
Extrapolate risk to low
doses |
|
ß |
|
An estimate of carcinogenic potency |
Uncertainties in low-dose
extrapolation methods
Linerized Multistage Model
|
|
|
P(d) = 1 – exp[-(q0 + q1d
+ q2d2 + …+ qkdk)] |
|
|
|
q1 – coefficient of linear
term |
|
|
|
q1* – upper 95% confidence
limit of q1 |
|
|
|
– also called Slope Factor (SF) |
|
|
|
– used by EPA for carcinogenic
potency |
Methylene Chloride Slope
Factor
4. Risk Characterization
|
|
|
Calculate risk by comparing calculated
dose to dose-response |
|
|
|
Noncancer: No risk if dose is less than
safe dose (RfD) |
|
|
|
Cancer: Risk = dose ´ Slope Factor |
Example – methylene
chloride
|
|
|
Dose = 2.3 × 10-3 mg MC/kg/day |
|
RfD = 6 × 10-2 mg/kg/day |
|
→ Dose is less than RfD so no
noncancer risk |
|
SF = 7.5 × 10-3 per
(mg/kg/day) |
|
Risk = 1.7 × 10-5 |
Risk assessment is done!
Rules of thumb
|
|
|
If risk is less than 10-6
rarely take action |
|
|
|
If risk is greater than 10-4
usually take action |
|
|
|
|
Cost-Benefit Analysis
|
|
|
|
Risk analysis: |
|
How many premature deaths would action X
prevent? |
|
Cost analysis: |
|
How much would action X cost? |
|
Benefit analysis: |
|
How much is preventing each premature
death worth? |
Approaches to benefit
analysis
|
|
|
|
Human capital |
|
Willingness-to-pay |
|
Survey |
|
Occupational behavior |
|
Consumer behavior |
|
Credible range from above: |
|
$2.1 million to $11 million (1995
dollars) |
|
$2.5 million to $13 million (2003
dollars) |
Risk Perception
|
|
|
Dread Factor |
|
Perceived as More Risky Perceived as Less
Risky |
|
Uncontrollable Controllable |
|
Involuntary Voluntary |
|
Inequitable Equitable |
|
Dread result Commonplace result |
|
Global consequences Localized
consequences |
|
Risk to future generations Risk to
existing people |
Risk Perception (continued)
|
|
|
Familiarity Factor |
|
Perceived as More Risky Perceived as Less
Risky |
|
New risk Old risk |
|
Not observable Observable |
|
Delayed effect Immediate effect |
|
No scientific consensus Scientific
consensus |
|
|
EPA's Seven Cardinal Rules
of Risk Communication
|
|
|
CR 1 — Accept and involve the public as
a legitimate partner. |
|
CR 2 — Plan carefully and evaluate your
performance. |
|
CR 3 — Listen to the public's concerns
and feelings. |
|
CR 4 — Be honest, open and frank. |
|
CR 5 — Coordinate and collaborate with
other credible sources. |
|
CR 6 — Meet the needs of the media. |
|
CR 7 — Speak clearly and with
compassion, kindness and respect. |
Guide to Ineffective Risk
Communication
|
|
|
1. Avoid eye contact, keep your arms
and legs crossed, and act nervous and/or bored |
|
2. Use jargon and mountains of
technical details |
|
3. Emphasize the benefits of industry
and the cost of cleanup |
|
|
|
|
Guide to Ineffective Risk
Communication (continued)
|
|
|
4. Blame others for mistakes and
confusion |
|
5. Make unrealistic promises |
|
6. Be sarcastic when people express
concerns or don't understand you |
|
7. Give long, prepared, technical
speeches when someone asks a question |
Guide to Ineffective Risk
Communication (continued)
|
|
|
|
|
8. Get angry; attack opponents |
|
9. Refuse to answer personal questions |
|
10. Minimize risks and make
inappropriate comparisons |
Bottom Line
|
|
|
|
|
Risk assessment can’t give the “right”
answer |
|
|
|
More modest goal: |
|
Assessments are |
|
Consistent |
|
Transparent |